Charles Schwab’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-12,699	Closed	-$152K	–	3666
2022 Q1	$152K	Sell	12,699 -1,574	-11%	-$28.2K	﹤0.01%	3351
2021 Q4	$466K	Sell	14,273 -6	-0%	-$243	﹤0.01%	3172
2021 Q3	$639K	Sell	14,279 -24,901	-64%	-$1.22M	﹤0.01%	3058
2021 Q2	$2.14M	Buy	39,180 +2,863	+8%	+$169K	﹤0.01%	2697
2021 Q1	$2.72M	Buy	36,317 +12,022	+49%	+$1.25M	﹤0.01%	2563
2020 Q4	$2.64M	Sell	24,295 -16	-0.1%	-$1.46K	﹤0.01%	2522
2020 Q3	$2.15M	Sell	24,311 -778	-3%	-$88.4K	﹤0.01%	2472
2020 Q2	$2.67M	Buy	25,089 +4,572	+22%	+$410K	﹤0.01%	2313
2020 Q1	$1.22M	Sell	20,517 -18	-0.1%	-$1.22K	﹤0.01%	2442
2019 Q4	$1.42M	Buy	20,535 +626	+3%	+$38K	﹤0.01%	2505
2019 Q3	$2.07M	Sell	19,909 -488	-2%	-$46.1K	﹤0.01%	2364
2019 Q2	$1.89M	Buy	20,397 +9,108	+81%	+$634K	﹤0.01%	2388
2019 Q1	$1.03M	Sell	11,289 -1,414	-11%	-$98.5K	﹤0.01%	2541
2018 Q4	$708K	Sell	12,703 -203	-2%	-$15.4K	﹤0.01%	2645
2018 Q3	$1.54M	Buy	12,906 +1,697	+15%	+$197K	﹤0.01%	2504
2018 Q2	$1.15M	Buy	11,209 +3,535	+46%	+$438K	﹤0.01%	2550
2018 Q1	$997K	Buy	7,674 +3,331	+77%	+$364K	﹤0.01%	2514
2017 Q4	$423K	Buy	4,343 +172	+4%	+$23.1K	﹤0.01%	2771
2017 Q3	$614K	Buy	4,171 +2,041	+96%	+$384K	﹤0.01%	2659
2017 Q2	$343K	Buy	+2,130	New	+$335K	﹤0.01%	2817

Other funds holding SYRS